Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence
Urgency urinary incontinence is characterized by unpredictable loss of urine; it is a prevalent condition that occurs disproportionately in women, affecting up to 19% of older women in the United States.1 Anticholinergic medications are used as the primary treatment for this condition. A recent systematic review of trials comparing treatments for urgency urinary incontinence showed that none of the six drugs evaluated was superior to another in treating the condition and that current evidence was insufficient to guide the choice among other therapies, including injections of botulinum toxin.2 OnabotulinumtoxinA is effective in treating urgency urinary incontinence that is resistant to . . .